MIMS Supported Resources

MIMS Supported Resources provides healthcare professionals with access to relevant resources supported by external organisations.

If you would like to reach our audience of GPs, nurses and pharmacists by hosting your resource(s) in print, video or audio format on MIMS, please contact our team via our advertising and sponsorship page. Content must be compliant with MIMS editorial standards.

INFLAMMATORY SKIN CONDITIONS
Published 28 November 2023
A digital MIMS supplement covering:
  • Understand the prevalence of inflammatory skin conditions
  • Find out about the physical and psychological impact of these conditions on patients
  • Learn more about treatment options for four common conditions and how to approach holistic management

NEW PRODUCT
QUVIVIQ TM ▼ (daridorexant) 50mg, 25mg tablets

View prescribing information

Promotional information from Idorsia Pharmaceuticals Ltd, developed in partnership with Haymarket Media Group. For UK healthcare professionals only.
UK-DA-00133 | November 2023

Adverse events should be reported.
Healthcare professionals are asked to report any suspected adverse reactions via www.mhra.gov.uk/yellowcard or search for
MHRA Yellow Card in Google play or Apple App store. Adverse events should also be reported to ds.safety.uk@idorsia.com.

NEW MILD ASTHMA INDICATION
Symbicort ® Turbohaler 200/6 (budesonide/formoterol)

View prescribing information

Promotional information from AstraZeneca UK Limited, developed in partnership with Haymarket Media Group. For UK healthcare professionals only.
GB-46957 | August 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.

NEW PRODUCT
Desmopressin Sublingual Tablets

View prescribing information

Promotional information from Morningside Pharmaceuticals Ltd, developed in partnership with Haymarket Media Group. For UK healthcare professionals only.
10103472042 v1.0 | August 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google play or Apple App store. Adverse events should also be reported to Morningside Pharmaceuticals Ltd's Medical Information department on 0116 478 0322.

Contraception and HRT
Published 18 May 2023
A digital MIMS supplement covering:
  • Overview of the menstrual cycle and menopause
  • Factors affecting contraceptive choice
  • Use of HRT in menopause
  • Contraception for women over 40
  • Benefits and risks of HRT

This site is intended for healthcare professionals.